Deepfake Technology in Drug Design
globenewswire.com
news
2022-10-20 17:00:00

New York, Oct. 20, 2022 (GLOBE NEWSWIRE) -- Insilico Medicine, a clinical-stage artificial intelligence (AI)-driven drug discovery company, is utilizing the same deepfake technology used to create artwork and lifelike images of virtual human beings to design new molecules that have the potential to treat disease. Insilico's end-to-end AI platform, Pharma.AI, can discover new targets, design new drugs, and, now, predict the outcomes of clinical trials. This technology can substantially improve the time and cost to bring new life-saving drugs to market.
